Clinical Trials Browser

Phase 1/2 × Solid Cancer × trastuzumab deruxtecan × Clear all

NCT06771622 2026-02-04

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

Phase 1/2 Active not recruiting

Solid Cancer